- Filed
- Sep 26, 2025 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jul 25, 2025 | 74.64M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 74.64M sh |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 74.64M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$13.23K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$39.01K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $33.3K |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $46.29K |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$193.7K |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$231.45K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $373.91K |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $372.34K |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $373.91K |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $391.47K |
| Current Assets | Q1 2025 · Mar 31, 2025 | $205.15K |
| Current Assets | Q1 2025 · Dec 31, 2024 | $129.02K |
| Total Assets | Q1 2025 · Mar 31, 2025 | $243.09K |
| Total Assets | Q1 2025 · Dec 31, 2024 | $222.66K |
| Eps Diluted restated | Q1 2025 · Mar 31, 2025 | $0.00 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic restated | Q1 2025 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.00 |
| Net Income | Q1 2025 · Mar 31, 2025 | $37.5K |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$46.55K |
| Operating Income restated | Q1 2025 · Mar 31, 2025 | $40.14K |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$46.56K |
| Gross Profit restated | Q1 2025 · Mar 31, 2025 | $116.72K |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2025 | $124.35K |
| Revenue restated | Q1 2025 · Mar 31, 2025 | $241.07K |